Literature DB >> 8595161

Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy.

H Mizuguchi1, M Nakanishi, T Nakanishi, T Nakagawa, S Nakagawa, T Mayumi.   

Abstract

Previously we reported that fusogenic liposomes, prepared by fusing simple liposomes with Sendai virus particles, could introduce their contents directly and efficiently into the cytoplasm. In this study, we examined the anti-tumour activity of fusogenic liposomes containing fragment A of diphtheria toxin (DTA). Fusogenic liposomes containing DTA showed high cytotoxicity against sarcoma-180 (S-180) cells in vitro. When these liposomes were administered into the abdominal cavity of ddY mice carrying S-180, tumour cells completely disappeared in four of six tumour-bearing mice without decrease in body weight. Neither simple liposomes containing DTA nor empty fusogenic liposomes had any effect on tumour suppression. We conclude that fusogenic liposomes containing DTA are new and potentially effective tools for the treatment of ascites tumours without any severe side-effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8595161      PMCID: PMC2074455          DOI: 10.1038/bjc.1996.83

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes.

Authors:  C Y Wang; L Huang
Journal:  Biochemistry       Date:  1989-11-28       Impact factor: 3.162

2.  Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus).

Authors:  M Nakanishi; T Uchida; H Sugawa; M Ishiura; Y Okada
Journal:  Exp Cell Res       Date:  1985-08       Impact factor: 3.905

3.  T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.

Authors:  P Casellas; S Ravel; B J Bourrié; J M Derocq; F K Jansen; G Laurent; P Gros
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

4.  Diphtheria toxin: quantification and assay.

Authors:  S F Carroll; R J Collier
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

5.  One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell.

Authors:  M Yamaizumi; E Mekada; T Uchida; Y Okada
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

6.  Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols.

Authors:  D Collins; D C Litzinger; L Huang
Journal:  Biochim Biophys Acta       Date:  1990-06-27

7.  Specific purification of elongation factor 2 and isolation of its antibody.

Authors:  K Takamatsu; T Uchida; Y Okada
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

8.  Interactions of liposome bilayers composed of 1,2-diacyl-3-succinylglycerol with protons and divalent cations.

Authors:  A M Tari; N Fuller; L T Boni; D Collins; P Rand; L Huang
Journal:  Biochim Biophys Acta       Date:  1994-06-22

9.  Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment.

Authors:  M Colombatti; L Dell'Arciprete; R Chignola; G Tridente
Journal:  Cancer Res       Date:  1990-03-01       Impact factor: 12.701

10.  Reconstitution of lipid vesicles associated with HVJ (Sendai virus) sikes. Purification and some properties of vesicles containing nontoxic fragment A of diphtheria toxin.

Authors:  T Uchida; J Kim; M Yamaizumi; Y Miyake; Y Okada
Journal:  J Cell Biol       Date:  1979-01       Impact factor: 10.539

View more
  2 in total

Review 1.  Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy.

Authors:  Andrea L J Marschall
Journal:  BioDrugs       Date:  2021-10-27       Impact factor: 5.807

2.  Molecular approaches to sarcoma therapy.

Authors:  R J Olsen; S R Tarantolo; S H Hinrichs
Journal:  Sarcoma       Date:  2002
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.